GLUE
MONTE ROSA THERP (GLUE)
NASDAQ
$17.57-$0.17 (-0.99%)
Price as of Jun 03, 2026 5:50 PM EDT
  • $1.7B
    Market Cap
  • 282.33%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
123.7M
+63.54%
75.6M
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
123.7M
+63.54%
75.6M
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-141.5M
+16.40%
-121.6M
+9.25%
-111.3M
+30.81%
-85.1M
+48.83%
Depreciation and Amortization Expense
8.4M
+2.89%
8.1M
+30.52%
6.2M
+66.14%
3.7M
+75.66%
Total Operating Expenses
177.9M
+13.49%
156.7M
+9.37%
143.3M
+27.52%
112.4M
+54.20%
Operating Profit
-54.2M
-33.17%
-81.1M
-43.40%
-143.3M
+27.52%
-112.4M
+54.20%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-140,000
-19.54%
-174,000
-12.12%
-198,000
+942.11%
-19,000
N/A
Interest Income and Expense and Net
-140,000
-19.54%
-174,000
-12.12%
-198,000
+942.11%
-19,000
N/A
Total Nonoperating Income and Expense
14.5M
+31.90%
11.0M
+32.36%
8.3M
+113.67%
3.9M
+460.87%
Income before Taxes
-39.7M
-43.36%
-70.1M
-48.06%
-135.0M
+20.14%
-112.4M
+54.20%
Income Taxes
-1.1M
-142.68%
2.6M
+660.36%
338,000
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-38.6M
-46.87%
-72.7M
-46.29%
-135.4M
+24.75%
-108.5M
+46.71%
Net Income from Continuing Operations Applicable to Common
-39.7M
-43.36%
-70.1M
-48.06%
-135.0M
+24.44%
-108.5M
+46.71%
Basic EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Diluted EPS and Net Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Basic Weighted Average Shares
83.1M
+12.40%
73.9M
+43.80%
51.4M
+8.83%
47.2M
+88.91%
Diluted Weighted Average Shares
83.1M
+12.40%
73.9M
+43.80%
51.4M
+8.83%
47.2M
+88.91%
Balance Sheet
Cash and Cash Equivalents
129.9M
-42.08%
224.3M
+75.06%
128.1M
+133.28%
54.9M
-84.13%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
129.9M
-42.08%
224.3M
+75.06%
128.1M
+133.28%
54.9M
-84.13%
Total Current Assets
393.2M
+4.17%
377.4M
+59.79%
236.2M
-14.38%
275.9M
-20.87%
Accumulated Depreciation
27.6M
+35.60%
20.4M
+66.32%
12.2M
+95.87%
6.3M
+131.26%
Property and Plant and Equipment and Net
26.0M
-11.86%
29.5M
-12.78%
33.8M
+24.85%
27.1M
+119.68%
Total Long-Term Assets
148,000
+28.70%
115,000
-67.33%
352,000
+26.62%
278,000
-97.74%
Total Assets
448.7M
+2.26%
438.7M
+44.44%
303.8M
-11.28%
342.4M
-6.54%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
64.2M
-59.09%
156.9M
+236.85%
46.6M
+82.22%
25.6M
+53.68%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
34.8M
-10.79%
39.0M
-9.04%
42.9M
-2.27%
43.9M
N/A
Total Liabilities
215.6M
-0.09%
215.8M
+73.32%
124.5M
+75.42%
71.0M
+277.25%
Retained Earnings
-477.2M
+8.81%
-438.6M
+19.87%
-365.9M
+58.71%
-230.5M
+88.91%
Total Stockholders Equity
233.1M
+4.54%
222.9M
+24.37%
179.3M
-33.96%
271.4M
-21.90%
Total Shares Outstanding
65.5M
+6.56%
61.5M
+22.67%
50.1M
+1.66%
49.3M
+5.99%
Cash Flow
Cash from Operating Activities
-22.8M
-154.29%
42.0M
+195.88%
-43.8M
-52.63%
-92.5M
+55.76%
Capital Expenditures
4.7M
+17.85%
4.0M
-79.06%
19.0M
+47.48%
12.9M
+32.67%
Cash from Investing Activities
-101.8M
+129.09%
-44.5M
-150.06%
88.8M
+140.51%
-219.2M
+2,170.99%
Dividends Paid
0
N/A
0
N/A
0
N/A
0
N/A
Cash from Financing Activities
30.4M
-69.31%
98.9M
+259.71%
27.5M
+34.33%
20.5M
-94.58%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-43.83%
-59.13%
-107.26%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-8.71%
-55.55%
-19.58%
-53.26%
-41.90%
+36.83%
-30.62%
N/A
Return on Equity
-16.94%
-53.14%
-36.15%
-39.81%
-60.07%
+71.32%
-35.06%
N/A
Revenue Growth
63.54%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
6.12
+154.61%
2.40
-52.56%
5.07
-53.01%
10.79
N/A
Cash Ratio
2.02
+41.56%
1.43
-48.03%
2.75
+28.02%
2.15
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow